Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 1—January 2013

Dispatch

Linezolid Dependence in Staphylococcus epidermidis Bloodstream Isolates

Spyros PournarasComments to Author , Eleni Ntokou, Olympia Zarkotou, Kyriaki Ranellou, Katerina Themeli-Digalaki, Constantinos Stathopoulos, and Athanassios Tsakris
Author affiliations: Author affiliations: University of Thessaly Medical School, Larissa, Greece (S. Pournaras, E. Ntokou); Tzaneio General Hospital, Piraeus, Greece (O. Zarkotou, K. Themeli-Digalaki); University of Athens Medical School, Athens, Greece (K. Ranellou, A. Tsakris); University of Patras School of Medicine, Patras, Greece (C. Stathopoulos)

Main Article

Table 1

Demographic and clinical characteristics of 27 patients with bloodstream infections who yielded linezolid-resistant Staphylococcus epidermidis, Greece, 2008–2010

Patient characteristics Finding
Mean age, y, ± SD 46.9 ± 21.7
Male sex, no. (%) 16 (59.3)
Comorbidities >2, no. (%) 8 (29.6)
Mean hospital stay, d ± SD 27.1 ± 9.8
Use of mechanical ventilation

Isolates recovered during ventilation, no. (%)

21 (77.8)

Mean duration, d ± SD

23.4 ± 9.7
Presence of central venous catheter

No. (%) patients

27 (100)

Mean duration, d ± SD

27.1 ± 9.8
Presence of foreign material, no. (%) 11 (40.7)
Admission from other hospital, no. (%) 6 (22.2)
Prior hospitalization, no. (%) 10 (37.0)
Linezolid administration

No. (%) patients

25 (92.6)

Mean duration, d ± SD

12.9 ± 7.4
In-hospital deaths, % 18.5

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO